Quotient Sciences
Garnet Valley, PA, United States quotientsciences.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Quotient Sciences provides integrated contract research, development, and manufacturing services for small molecule and synthetic peptide drug programs. It supports pharma and biotech clients across early clinical development, drug product development and manufacturing, and commercial supply from facilities in the US and UK.
Services
Drug Product Development & Manufacturing
Formulation development and drug product manufacturing services from preclinical stages through commercial supply.
Early Clinical Development
First-in-human and clinical pharmacology programs, including Phase I and Phase I/IIa studies.
Assays & in vitro testing
Translational Pharmaceutics® Integrated Drug Development
An integrated approach combining formulation development, drug product manufacturing, and clinical testing in one program.
Clinical Pharmacology Studies
Exploratory and regulatory-driven Phase 1 clinical pharmacology studies such as DDI, human ADME, BA/BE, food effect, and TQT.
Assays & in vitro testing
Human ADME Studies
Integrated human mass balance and 14C radiolabeled ADME studies for regulatory filings.
Assays & in vitro testing
Pharmacy Compounding
Integrated pharmacy compounding and GMP manufacturing to support first-in-human clinical testing and later proof-of-concept trials.
Commercial Drug Product Manufacturing
Commercial manufacturing and sustained supply for solid oral dosage forms, including niche and small-volume products.
CDMO: development & manufacturing
Scale-Up & CDMO Tech-Transfer
Technology transfer and scale-up support from lab or pilot scale into registration batches and commercial supply.
High Potency API Handling & Drug Product Manufacturing
Handling and manufacturing of intermediates and finished drug products containing HPAPIs.
CDMO: development & manufacturing
Pediatric Formulation Development
Customized pediatric formulations, taste masking, taste assessment, PK studies, and pediatric drug product manufacturing.
Drug Substance Synthesis & Manufacturing
Drug substance services including route scouting, PR&D, small-scale GMP manufacture, DOE/QbD, and 14C labelling.
Preclinical Technology Screening
Preclinical screening to help assess molecule developability before clinical evaluation.
Clinical Trial Manufacturing
Manufactures drug product for clinical trials, including batch manufacturing and patient-specific supply.
Commercial Manufacturing
Produces drug products for commercial supply, including low-volume and niche products and small batch sizes.
Global Clinical Trial Supplies
Manages manufacturing and supply logistics for clinical trial materials.
AI-Enhanced Formulation Development
Uses a proprietary AI approach to optimize formulation composition and dose selection during clinical study.
- Turnaround
- Less than seven days
- What to send
- 14C drug products tailored to specific program requirements · IV products where appropriate for human ADME studies
- Minimums and prices
- $8-30 million savings in runway costs by reaching proof-of-concept sooner
Capabilities
- Assays and studies
- Small molecules · Peptides · Single ascending dose (SAD) · Multiple ascending dose (MAD) · Drug-drug interaction (DDI) · Human ADME · Bioavailability/bioequivalence (BA/BE) · Food effect · Thorough QT (TQT) · Bioanalysis · Pharmacokinetics · Statistics
7 more
Clinical programming · Pharmacodynamic studies · Biomarker studies · Pharmacokinetic studies · Taste assessment · Tablet dissolution · In vitro drug release - Scale and capacity
- More than 1,300 Phase I studies delivered · Database of 31,500+ active healthy volunteers · Two Philadelphia sites approved for Phase I–III clinical manufacturing and commercial drug product manufacturing · Third site in the planning stages · Batch sizes from less than 1 kg to over 400 kg · Up to 500 kg for solid oral dosage forms in commercial drug product · 2,500 ft² compounding pharmacy · Less than seven days for manufacture and release of drug products
- Therapeutic areas
- Inflammation · Metabolic diseases · CNS disorders · Oncology · Rare diseases · GI/gastroenterology · Cardiovascular · Dermatology · Endocrinology · GI · Haematology · Immunology
4 more
Hepatology · Infectious disease · Nephrology · Pediatrics
Instruments and platforms
- Translational Pharmaceutics®
- Synthesis-to-Clinic®
- PBLEC standards
- USP 795/797/800 clean room
- Proprietary AI algorithm
- Digital twin
Modalities and species
- Modalities
- Small molecule · Peptide
- Species and models
- Healthy volunteers · Special populations · Patient cohorts · Healthy smokers · Healthy elderly · High BMI · Post-menopausal women · Japanese · Chinese · Healthy participants
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: drug product manufacturing
Company
- Type
- CRDMO
- Founded
- 1990
Locations
- Based in
- Garnet Valley, PA, United States
- Sites
- Miami, United States · Nottingham, United Kingdom · Philadelphia, United States · Boothwyn, United States · Philadelphia, PA, United States
- Serves
- US, UK, global
Public records
- Parent company
- QUOTIENT SCIENCES LIMITED · GB GLEIF
- Biocom California CRO directory
- drug development, Drug Product Manufacturing, drug substance API manufacturing, Formulation Development, small molecule source
- FDA drug establishment registration
- 3003882011 · ANALYSIS; MANUFACTURE source
- CMS CLIA laboratory
- 10D1098266 · MIAMI source
Similar labs
Work here? Claim this listing